Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin.
Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis.
[Multiple sclerosis: oral drugs].
Neuroimaging assessment of spasticity developed after acquired brain injuries and multiple sclerosis.
Cell-Based Reparative Therapies for Multiple Sclerosis.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
Local assessment of myelin health in a multiple sclerosis mouse model using a 2D Fourier transform approach.
Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
[Anesthetic management of a Dialysis Patient with Chronic Inflammatory Demyelinating Polyneuropathy].
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
[Differential diagnosis of optic neuritis (review].
Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
[Multimodal complex treatment in advanced multiple sclerosis.]
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy.
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review.
The amyloid state of proteins in human diseases.
Multifocal VEP assessment of optic neuritis evolution.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
Pages
« first
‹ previous
…
551
552
553
554
555
556
557
558
559
…
next ›
last »